Skip to main content
Premium Trial:

Request an Annual Quote

University of California to Use Affymetrix GeneChip

Premium

SANTA CLARA, Calif.--The University of California has agreed to acquire Affymetrix's GeneChip technology under the company's academic access program. The plan calls for all University of California academic and medical institutions to gain preferential access to Affymetrix's standard and custom GeneChip arrays, instrumentation, and software to monitor gene expression for use in their research and development activities.

Affymetrix's academic access program is a volume-discount pricing arrangement designed for academic organizations that want broad access to GeneChip technology. Terms and conditions of the agreement between the university and Affymetrix will not interfere with academic researchers publishing their scientific results via traditional or emerging electronic means with their academic, government, and commercial scientific colleagues, said Affymetrix.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.